Efficient siRNA delivery using a polyamidoamine dendrimer with a modified pentaerythritol core

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Efficient delivery of small interfering RNA (siRNA) into cells is a significant challenge in developing gene-based therapies.
• Polyamidoamine (PAMAM) dendrimers are investigated for their potential as non-viral gene delivery vectors.
• A novel PD dendrimer, modified with a pentaerythritol derivative core, has previously demonstrated high plasmid DNA transfection efficiency and low cytotoxicity.

Purpose of the Study:

• To evaluate the efficacy of the novel PD dendrimer as a carrier for siRNA delivery.
• To characterize the formation and properties of PD dendrimer/siRNA nanoparticles (NPs).
• To investigate the cellular uptake mechanisms of PD dendrimer/siRNA NPs.

Main Methods:

• Agarose gel electrophoresis and Atomic Force Microscopy (AFM) were used to confirm the formation of generation 5 (G5)-PD dendrimer/siRNA NPs.
• SK Hep-1 cells with stable luciferase expression were transfected using G5 PD dendrimer/anti-luciferase siRNA NPs.
• The impact of various endocytic pathway inhibitors on the uptake of G5 PD dendrimer/siRNA NPs was examined.

Main Results:

• Agarose gel electrophoresis confirmed NP formation at weight ratios greater than 0.5:1 (G5 PD dendrimer:siRNA).
• Effective luciferase gene silencing was achieved with G5 PD dendrimer/siRNA NPs at weight ratios of 3.0:1 and higher.
• Clathrin-mediated endocytosis was identified as the primary pathway for cellular uptake of G5-PD dendrimer/siRNA NPs.

Conclusions:

• The novel G5 PD dendrimer exhibits significant siRNA delivery activity.
• The PD dendrimer demonstrates potential as an effective delivery agent for therapeutic applications involving siRNA.
• Further research into PD dendrimer-based siRNA delivery systems is warranted.